by rss feed | Oct 1, 2024 | Berkeley Biologics, CARsgen, FDA Warning Letter, FDA warning letters, News Feeds
This year already appears to be a record one for cell and tissue therapy-related warning letters the FDA. Directly or indirectly, these come from the FDA’s Center for Biologics Evaluation and Research or CBER. Something unusual seems to be happening. FDA’s...
